靜脈支架市場:各市場區隔規模，佔有率，法律規章，償付，介入，2036年為止的預測

靜脈支架是一種自膨脹金屬支架，帶有穿孔管，插入靜脈以防止因靜脈血管阻塞或阻塞而導致的血流變窄。在出現嚴重狹窄或外部壓迫的情況下，應考慮放置靜脈支架。該市場正在追蹤放置在髂股靜脈的靜脈支架。

慢性靜脈疾病 (CVD) 或慢性靜脈功能不全 (CVI) 是發展中國家和已開發國家的全球負擔。這是指腿部靜脈壁和瓣膜無法有效發揮作用的情況，導致血液從腿部回流到心臟變得越來越困難。深部靜脈血栓形成 (DVT) 是一種可能危及生命的疾病，人體的大而深部靜脈中會形成血栓。大多數 DVT 發生在近端或遠端髂股靜脈或骨盆內。 DVT 也可能發生在身體的其他部位。深部靜脈血栓形成 (DVT) 分為急性/亞急性和慢性。如果出現嚴重狹窄或外部壓迫，可以考慮放置靜脈支架。

本報告對全球靜脈支架市場進行了詳細分析，包括競爭格局、 SWOT 分析、 2036 年市場預測、區域和國家趨勢。

目錄

目前可用的靜脈支架和競爭格局

• 洞察關鍵產業趨勢
• 2015 年至 2036 年靜脈支架市場總收入（細分市場）及市場預測
• 細分市場劃分的干預措施總數、單位數、平均售價和市場價值的詳細數據

全球、地區和國家洞察

• 靜脈支架市場的 SWOT 分析
• 靜脈支架市場的競爭動態洞察與趨勢
• 各國衛生系統概覽
• 特定國家的報銷政策
• 各國醫療科技法規

Venous Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

A venous stent is a self-expandable metallic stent with perforated tube which is inserted into a vein to prevent the blood flow constriction caused by obstructions and occlusions in the venous vasculature. Venous stent placement is considered in case of significant stenosis or extrinsic compression. Venous stents placed in the iliofemoral vein have been tracked in this market.

Chronic Venous Disease (CVD) or Chronic venous insufficiency (CVI) has emerged as a global burden on developing and developed countries. It refers to the condition where venous walls and/or valves in the leg are not working efficiently and becomes increasingly difficult for blood to return to the heart from the legs. Deep Vein Thrombosis (DVT) is a potential life threating condition where a blood clot is formed in the large deep veins in the body. Most of the DVT occurs proximal or distal to the iliofemoral vein as well as in the pelvic area. They also can occur in other parts of the body. Deep Vein Thrombosis (DVT) can be characterized as acute/subacute and chronic. Venous stent placement is considered in case of significant stenosis or extrinsic compression.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Venous Stents market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Venous Stents market revenue by segment and market outlooks from 2015-2036.
• Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Venous Stents market.
• Competitive dynamics insights and trends provided Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Becton Dickinson and Co, CR Bard Inc, Cook Medical Inc, Medtronic Plc, OptiMed Medizinische Instrumente GmbH, Plus Medica GmbH.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

• CMO executives who must have deep understanding of the Venous Stents marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Venous Stents market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Venous Stents market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Venous Stents market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.